Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VEDOLIZUMAB vs VELIPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VEDOLIZUMAB vs VELIPARIB: Safety Overview

Metric VEDOLIZUMAB VELIPARIB
Total FAERS Reports 73,857 391
Deaths Reported 3,476 43
Death Rate 4.7% 11.0%
Hospitalizations 21,677 222
Average Patient Age 50.0 yrs 57.9 yrs
% Female Patients 56.5% 92.3%
Manufacturer Takeda Pharmaceuticals America, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A